Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

GlaxoSmithKline Pharmaceuticals Ltd.

Price on BSE   04 Nov,15:29 LIVE
2,644.50
-85.20
(-3.12%)

© 2024 Rediff.com
  • Volume :
  • 3,497.00
  • Prev Close :
  • 2,729.70
  • Day's H/L (Rs.) :
  • 2,729.70 - 2,602.00
  • 52wk H/L (Rs.) :
  • 3,087.95 - 1,387.90
  • Mkt Cap (Rs. Cr) :
  • 44,797.84
Price on NSE   04 Nov,15:59 LIVE
2,624.90
-108.20
(-3.96%)

© 2024 Rediff.com
  • Volume :
  • 143,629.00
  • Prev Close :
  • 2,733.10
  • Day's H/L (Rs.) :
  • 2,733.10 - 2,601.10
  • 52wk H/L (Rs.) :
  • 3,088.00 - 1,385.05
  • Mkt Cap (Rs. Cr) :
  • 0.00
Report Card - GlaxoSmithKline Pharmaceuticals Ltd.
PE Ratios
76.62
EPS (Rs.)
34.51
Sales (Rs. Cr)
1,000.05
Face Value (Rs.)
10
Net Profit Margin(%)
17.16
Last Bonus
1:1
Last Dividend(%)
120
Return on Average Equity
32.6

About GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia

News for Pharmaceuticals and health care

Royal Enfield Unveils Electric Bike Flying Flea C6 - 2026 Release
Royal Enfield enters the electric bike segment with the Flying Flea C6, a classic-styled model set to launch in 2026. Learn about their new EV brand, development, and future plans.
Nov 04, 2024 23:51
Sagility India IPO: Rs 945 Cr Anchor Investor Funding
Sagility India, a healthcare tech services provider, raised Rs 945 crore from anchor investors ahead of its IPO, which opens on November 5th.
Nov 04, 2024 22:28
Sebi Demands Rs 130 Crore from 5 Entities in Reliance Home Fin Case
Sebi has issued demand notices to five entities, including Netizen Engineering and Citi Securities, for Rs 130 crore in connection with the illegal diversion of funds from Reliance Home Finance.
Nov 04, 2024 22:03
Suzuki Unveils First Electric SUV: e Vitara
Suzuki launches its first mass-production battery electric vehicle, the e Vitara, in Europe. Production is set to begin in India in 2025 with global sales planned.
Nov 04, 2024 21:26
In-flight WiFi Access: New Rules Clarify Device Usage
India's new aviation rules clarify that in-flight WiFi is only available when electronic devices are permitted. Learn about the new regulations and their impact on passenger connectivity.
Nov 04, 2024 19:54

More News »

Top News

Royal Enfield Unveils Electric Bike Flying Flea C6 - 2026 Release
Royal Enfield enters the electric bike segment with the Flying Flea C6, a classic-styled model set to launch in 2026. Learn about their new EV brand, development, and future plans.
Nov 04, 2024 23:51
Sagility India IPO: Rs 945 Cr Anchor Investor Funding
Sagility India, a healthcare tech services provider, raised Rs 945 crore from anchor investors ahead of its IPO, which opens on November 5th.
Nov 04, 2024 22:28
Sebi Demands Rs 130 Crore from 5 Entities in Reliance Home Fin Case
Sebi has issued demand notices to five entities, including Netizen Engineering and Citi Securities, for Rs 130 crore in connection with the illegal diversion of funds from Reliance Home Finance.
Nov 04, 2024 22:03
Suzuki Unveils First Electric SUV: e Vitara
Suzuki launches its first mass-production battery electric vehicle, the e Vitara, in Europe. Production is set to begin in India in 2025 with global sales planned.
Nov 04, 2024 21:26
FSIB Recommends Rahul Bhave for IFCI MD Post
FSIB has recommended Rahul Bhave, currently Deputy Managing Director of IFCI, for the position of Managing Director and CEO of IFCI Ltd. The final decision will be taken by the Appointments...
Nov 04, 2024 21:14

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com